Related Experiment Video

Updated: Jul 7, 2026

The Extraction of Liver Glycogen Molecules for Glycogen Structure Determination
04:50

The Extraction of Liver Glycogen Molecules for Glycogen Structure Determination

Published on: February 8, 2022

[Natural history of hepatic glycogen storage diseases]

Philippe Labrune1, Pascale Trioche Eberschweiler, Alix Mollet Boudjemline

  • 1Service de pédiatrie, Centre de référence des maladies héréditaires du métabolisme hépatique, AP-HP, Hôpital Antoine Béclère, F-92141 Clamart Cedex, France. philippe.labrune@abc.aphp.fr

Presse Medicale (Paris, France : 1983)
|March 4, 2008
PubMed

Insights

Hepatic glycogen storage diseases (GSDs) are rare inherited metabolic disorders. Medical advances now allow affected children to reach adulthood, necessitating better long-term care strategies.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Context:

  • Hepatic glycogen storage diseases (GSDs) are rare inherited metabolic disorders impacting glycogen metabolism.
  • Significant medical advancements over the past two decades have improved survival rates for children with GSDs, enabling them to reach adulthood.

Purpose:

  • To understand the natural history and long-term outcomes of patients with hepatic GSDs.
  • To inform and enhance treatment strategies for children diagnosed with these conditions.

Summary:

  • Hepatic GSDs affect how the body stores and uses glycogen.
  • Improved survival means more patients are living into adulthood, requiring ongoing management.
  • Longitudinal data is crucial for optimizing pediatric care and transition to adult GSD management.

Impact:

  • Enhanced understanding of GSDs will guide improved pediatric treatment protocols.
  • Facilitates essential collaboration between pediatric and adult care specialists.
  • Aims to improve the overall quality of life and long-term health outcomes for individuals with hepatic GSDs.

More Related Videos

Detecting Glycogen in Peripheral Blood Mononuclear Cells with Periodic Acid Schiff Staining09:42

Detecting Glycogen in Peripheral Blood Mononuclear Cells with Periodic Acid Schiff Staining

Published on: December 23, 2014

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...